What were the SARS-CoV-2 seroprevalence estimates for industrial livestock operation workers in the USA for 2021-2022?

In a recent study posted to the medRxiv* preprint server, researchers measured severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) seroprevalence in industrial livestock operation (ILO) workers of North Carolina, United States (US), between February 2021 and July 2022.

Study: SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, USA, 2021-2022. Image Credit: CROCOTHERY/Shutterstock
Study: SARS-CoV-2 antibody prevalence among industrial livestock operation workers and nearby community residents, North Carolina, USA, 2021-2022. Image Credit: CROCOTHERY/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

North Carolina's ILOs, especially processing facilities, emerged as centers of coronavirus disease 2019 (COVID-19) outbreaks in the spring of 2020. However, confirmed COVID-19 cases underestimated true severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) seroprevalence. Yet, few studies pursued evidence of COVID-19-related health disparities by socioeconomic status and ethnicity in North Carolina, especially among rural, Black, and Hispanic communities.

Many people from these communities work in animal production, slaughtering, and processing facilities and suffer over 50% more injury and illness than all US workers. Taylor et al. estimated that ~8% of US COVID-19 cases through the summer of 2020 occurred among processing plant and agricultural workers.

North Carolina is the second-largest hog and fourth-largest poultry-producing US state; thus, people working in these facilities, their household members, and nearby communities are more prone to respiratory health problems and infectious diseases. Given the limited access to and availability of reverse transcription-polymerase chain reaction (RT-PCR) testing, SARS-CoV-2 antibody testing could prove an attractive alternative. It could help estimate COVID-19 infection rates, prevalence, and population immunity due to prior infection or vaccination, even among asymptomatic and mild cases. Furthermore, SARS-CoV-2 antibodies are present in saliva, which is easier to collect. Saliva could be readily self-collected at home and mailed to a testing lab.

About the study

In the present study, researchers enrolled 279 individuals from 240 households in collaboration with Rural Empowerment Association for Community Help (REACH), a community group based in Duplin County, North Carolina. They used a multiplex immunoassay to measure their salivary immunoglobulins G (IgG) responses targeting SARS-CoV-2. The team separately measured IgG responses to SARS-CoV-2 nucleocapsid (N), receptor-binding domain (RBD), and spike (S) protein to know whether these responses were antibody- or infection-triggered. At least one adult from ILO group households worked as an industrial hog/poultry operation worker or at an animal rendering or meat packing facility. For comparisons, they also enrolled participants living nearby these facilities but having no occupational exposure to livestock (ILO neighbors or ILON) and participants from metropolitan areas of North Carolina (Metro).

Study findings

The study analysis covered 80 participants in each cohort - ILO,  ILON, and Metro. Most participants in all groups were Black Americans. ILON participants were older; ~50% of ILO and ILON and 72.8% of Metro participants were female. Compared to ILO and Metro participants, ILON participants reported not having health insurance (13.3% and 8.7% vs. 15.5%). Likewise, compared to ILO and ILON, more Metro participants had received primary COVID-19 vaccination and at least one booster dose. (13.2% and 10.3% vs. 20.7%).

SARS-CoV-2-induced antibody prevalence among ILO workers and their household members was as high as 63% compared to participants with no household members working at ILO (45.6%). These findings highlight a higher SARS-CoV-2 transmission among meatpacking facility workers and their nearby communities. However, the authors did not observe elevated SARS-CoV-2 infection-induced IgG response in their study population.

The study population comprised barely 23 meatpacking workers but a relatively large number of Black participants in other high-COVID-19-risk jobs. Thus, COVID-19 seroprevalence was comparable between high ILO intensity regions and Metro region residents (42.9% and 48.7%). Also, over time case rates might have converged between these two areas. Intriguingly, although 51% of all study participants had SARS-CoV-2 infection-induced IgG, only 15.4% reported having tested COVID-19-positive. Although testing positive for infection-induced IgG, 68% of participants did not think they had COVID-19, also underlining the importance of accessible RT-PCR testing for COVID-19.

The more-infectious SARS-CoV-2 Delta and Omicron variants spread in the summer and winter of 2021, respectively. Thus, it is also significant that the median date of vaccination completion, including booster doses, was later for ILO compared to ILON and Metro participants. Furthermore, by July 2022, the ILO, ILON, and Metro combined had lower primary COVID-19 vaccination rates (52%) vs. North Carolina (62.9%) and US residents (67.2%). The study results, thus, also highlight the urgent need for dismantling vaccination barriers, especially for ILO workers, their household members, and rural communities.

Living and working in closed, crowded conditions could increase exposure to SARS-CoV-2 from household members and coworkers. Thus, participants with more than one person per household bedroom had a higher prevalence of SARS-CoV-2 infection-induced IgG. Also, it was higher among Hispanic/Latino and Black individuals than White Americans because of their occupational status disadvantages within specific jobs.

Conclusions

The current study results add to reports of high COVID-19 case rates among meatpacking facility workers early in the pandemic by reporting that ILO workers and their families exhibited high rates of SARS-CoV-2 infection-induced IgG. The study results also evidenced health disparities in exposure to SARS-CoV-2 by socioeconomic position.

Indeed, there is an urgent need to vaccinate ILO workers and their families as a priority because they are at a higher risk of contracting COVID-19 compared to the general population and are similarly susceptible as workers in other high-COVID-19-risk occupations (e.g., healthcare workers).

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 16 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Neha Mathur

Written by

Neha Mathur

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mathur, Neha. (2023, May 16). What were the SARS-CoV-2 seroprevalence estimates for industrial livestock operation workers in the USA for 2021-2022?. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20221104/What-were-the-SARS-CoV-2-seroprevalence-estimates-for-industrial-livestock-operation-workers-in-the-USA-for-2021-2022.aspx.

  • MLA

    Mathur, Neha. "What were the SARS-CoV-2 seroprevalence estimates for industrial livestock operation workers in the USA for 2021-2022?". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20221104/What-were-the-SARS-CoV-2-seroprevalence-estimates-for-industrial-livestock-operation-workers-in-the-USA-for-2021-2022.aspx>.

  • Chicago

    Mathur, Neha. "What were the SARS-CoV-2 seroprevalence estimates for industrial livestock operation workers in the USA for 2021-2022?". News-Medical. https://www.news-medical.net/news/20221104/What-were-the-SARS-CoV-2-seroprevalence-estimates-for-industrial-livestock-operation-workers-in-the-USA-for-2021-2022.aspx. (accessed November 23, 2024).

  • Harvard

    Mathur, Neha. 2023. What were the SARS-CoV-2 seroprevalence estimates for industrial livestock operation workers in the USA for 2021-2022?. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20221104/What-were-the-SARS-CoV-2-seroprevalence-estimates-for-industrial-livestock-operation-workers-in-the-USA-for-2021-2022.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Public trust in COVID-19 vaccine science influences vaccine uptake in the US